Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q3

2372.TEDINET S100SRTF
Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥12.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥13.9bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥810m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥3.0bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥972m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥972m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥36.5bnat 2023-12-31Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥32.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥24.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.8bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥80.332023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-9.892023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥185.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.052022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥184.942022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio33.8%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥265m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥224m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥566m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥0
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.4bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2023-04-01 → 2023-12-31−¥130m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥938m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-12-31¥51m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-12-31¥801m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥664m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-12-31¥7.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥617m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.8bn
—segment totalrevenue2023-04-01 → 2023-12-31¥16.1bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥12.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.4bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥16.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥101m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥67m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥951m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31−¥102m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-12-31¥4.1bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.0bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥97m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-12-31−¥70m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-12-31¥818m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥691m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-12-31¥72m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-12-31¥8.1bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥115m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥14.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥13.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥907m
—segment totalsegment profit2022-04-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥953m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 410
ItemContextValueUnit
Shareholders equityPrior1YearInstant12006000000JPY
Shareholders equityCurrentQuarterInstant12132000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant107000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant166000000JPY
Foreign currency translation adjustmentPrior1YearInstant33000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant59000000JPY
Valuation and translation adjustmentsPrior1YearInstant141000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant226000000JPY
Non controlling interestsPrior1YearInstant6000000JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant12154000000JPY
Net assetsCurrentQuarterInstant12358000000JPY
Liabilities and net assetsPrior1YearInstant35129000000JPY
Liabilities and net assetsCurrentQuarterInstant36545000000JPY
Net salesPrior1YTDDuration13896000000JPY
Net salesCurrentYTDDuration12868000000JPY
Cost of salesPrior1YTDDuration7015000000JPY
Cost of salesCurrentYTDDuration7328000000JPY
Gross profitPrior1YTDDuration6881000000JPY
Gross profitCurrentYTDDuration5540000000JPY
Directors compensations sgaPrior1YTDDuration364000000JPY
Directors compensations sgaCurrentYTDDuration378000000JPY
Salaries allowances and bonuses sgaPrior1YTDDuration1520000000JPY
Salaries allowances and bonuses sgaCurrentYTDDuration1799000000JPY
Commission fee sgaPrior1YTDDuration137000000JPY
Commission fee sgaCurrentYTDDuration167000000JPY
Rent expenses sgaPrior1YTDDuration315000000JPY
Rent expenses sgaCurrentYTDDuration374000000JPY
Research and development expenses sgaPrior1YTDDuration495000000JPY
Research and development expenses sgaCurrentYTDDuration521000000JPY
Other sgaPrior1YTDDuration1018000000JPY
Other sgaCurrentYTDDuration1487000000JPY
Selling general and administrative expensesPrior1YTDDuration3853000000JPY
Selling general and administrative expensesCurrentYTDDuration4729000000JPY
Operating incomePrior1YTDDuration3027000000JPY
Operating incomeCurrentYTDDuration810000000JPY
Interest income noiPrior1YTDDuration97000000JPY
Interest income noiCurrentYTDDuration17000000JPY
Dividends income noiPrior1YTDDuration0JPY
Dividends income noiCurrentYTDDuration0JPY
Gain on sales of investment securities noiPrior1YTDDuration－JPY
Gain on sales of investment securities noiCurrentYTDDuration11000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration7000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration－JPY
Subsidy income noi bountyPrior1YTDDuration56000000JPY
Subsidy income noi bountyCurrentYTDDuration46000000JPY
Foreign exchange gains noiPrior1YTDDuration48000000JPY
Foreign exchange gains noiCurrentYTDDuration295000000JPY
Land and house rent received noiPrior1YTDDuration2000000JPY
Land and house rent received noiCurrentYTDDuration146000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass